drugset / Trial / NCT06928779
Effects of Hepatic Impairment on the Pharmacokinetics of Dazucorilant
Non-randomizedParallel-groupOpen-labelTreatment
Summary
This study will compare the pharmacokinetics (PK) of dazucorilant (CORT113176) between participants with normal hepatic function and participants with hepatic impairment.
Timeline
- Start
- 2024-10-08
- Primary completion
- 2024-12-09
- Completion
- 2024-12-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dazucorilant | Small molecule | 300 mg | Oral |
Indications
No indication recorded.